Soluble complement receptor type 1 and cobra venom factor in discordant xenotransplantation. 1996

D Candinas, and B A Lesnikoski, and S C Robson, and S M Scesney, and I Otsu, and T Myiatake, and H C Marsh, and U S Ryan, and W W Hancock, and F H Bach
Sandoz Center for Immunobiology, New England Deaconness Hospital, Harvard Medical School, Boston, Mass. 02215, USA.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D011951 Receptors, Complement Molecules on the surface of some B-lymphocytes and macrophages, that recognize and combine with the C3b, C3d, C1q, and C4b components of complement. Complement Receptors,Complement Receptor,Complement Receptor Type 1,Receptor, Complement
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D004546 Elapid Venoms Venoms from snakes of the family Elapidae, including cobras, kraits, mambas, coral, tiger, and Australian snakes. The venoms contain polypeptide toxins of various kinds, cytolytic, hemolytic, and neurotoxic factors, but fewer enzymes than viper or crotalid venoms. Many of the toxins have been characterized. Cobra Venoms,Elapidae Venom,Elapidae Venoms,Naja Venoms,Cobra Venom,Elapid Venom,Hydrophid Venom,Hydrophid Venoms,King Cobra Venom,Naja Venom,Ophiophagus hannah Venom,Sea Snake Venom,Sea Snake Venoms,Venom, Cobra,Venom, Elapid,Venom, Elapidae,Venom, Hydrophid,Venom, King Cobra,Venom, Naja,Venom, Ophiophagus hannah,Venom, Sea Snake,Venoms, Cobra,Venoms, Elapid,Venoms, Elapidae,Venoms, Hydrophid,Venoms, Naja,Venoms, Sea Snake
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft

Related Publications

D Candinas, and B A Lesnikoski, and S C Robson, and S M Scesney, and I Otsu, and T Myiatake, and H C Marsh, and U S Ryan, and W W Hancock, and F H Bach
January 1994, Transplant international : official journal of the European Society for Organ Transplantation,
D Candinas, and B A Lesnikoski, and S C Robson, and S M Scesney, and I Otsu, and T Myiatake, and H C Marsh, and U S Ryan, and W W Hancock, and F H Bach
December 2004, Zhonghua yi xue za zhi,
D Candinas, and B A Lesnikoski, and S C Robson, and S M Scesney, and I Otsu, and T Myiatake, and H C Marsh, and U S Ryan, and W W Hancock, and F H Bach
December 1997, The International journal of neuroscience,
D Candinas, and B A Lesnikoski, and S C Robson, and S M Scesney, and I Otsu, and T Myiatake, and H C Marsh, and U S Ryan, and W W Hancock, and F H Bach
January 1996, Advances in experimental medicine and biology,
D Candinas, and B A Lesnikoski, and S C Robson, and S M Scesney, and I Otsu, and T Myiatake, and H C Marsh, and U S Ryan, and W W Hancock, and F H Bach
February 2001, Xenotransplantation,
D Candinas, and B A Lesnikoski, and S C Robson, and S M Scesney, and I Otsu, and T Myiatake, and H C Marsh, and U S Ryan, and W W Hancock, and F H Bach
January 2010, Xenotransplantation,
D Candinas, and B A Lesnikoski, and S C Robson, and S M Scesney, and I Otsu, and T Myiatake, and H C Marsh, and U S Ryan, and W W Hancock, and F H Bach
November 1998, Xenotransplantation,
D Candinas, and B A Lesnikoski, and S C Robson, and S M Scesney, and I Otsu, and T Myiatake, and H C Marsh, and U S Ryan, and W W Hancock, and F H Bach
November 2012, Biomaterials,
D Candinas, and B A Lesnikoski, and S C Robson, and S M Scesney, and I Otsu, and T Myiatake, and H C Marsh, and U S Ryan, and W W Hancock, and F H Bach
January 2007, Current pharmaceutical design,
D Candinas, and B A Lesnikoski, and S C Robson, and S M Scesney, and I Otsu, and T Myiatake, and H C Marsh, and U S Ryan, and W W Hancock, and F H Bach
October 1993, The Journal of thoracic and cardiovascular surgery,
Copied contents to your clipboard!